TerrAscend Corp. (TSND.TO)
CAD 0.62
(21.57%)
CAD 0.62
(21.57%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -1.02 Million USD | 6848.99% |
| 2022 | -320.93 Million USD | -98.04% |
| 2021 | 104.53 Million USD | 275.38% |
| 2020 | -96.44 Million CAD | 43.37% |
| 2019 | -204.22 Million CAD | -111.94% |
| 2018 | -20.51 Million CAD | -324.72% |
| 2017 | -6.56 Million CAD | -639.63% |
| 2016 | -866.94 Thousand CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 13.51 Million USD | 1.04% |
| 2024 Q1 | 19.18 Million USD | 153.2% |
| 2023 Q4 | 23.88 Million USD | -18.68% |
| 2023 Q1 | 12.66 Million USD | -23.49% |
| 2023 Q2 | 12.05 Million USD | -4.84% |
| 2023 Q3 | 29.37 Million USD | 143.65% |
| 2023 FY | - USD | 6848.99% |
| 2022 Q3 | -659.6 Thousand CAD | 91.89% |
| 2022 Q1 | -5.64 Million CAD | 71.02% |
| 2022 FY | - USD | -98.04% |
| 2022 Q4 | 16.55 Million CAD | 2610.22% |
| 2022 Q2 | -8.13 Million CAD | -44.07% |
| 2021 Q4 | -19.48 Million CAD | -1.23% |
| 2021 FY | - USD | 275.38% |
| 2021 Q3 | -19.24 Million CAD | 0.0% |
| 2020 FY | - CAD | 43.37% |
| 2019 FY | - CAD | -111.94% |
| 2018 FY | - CAD | -324.72% |
| 2017 FY | - CAD | -639.63% |
| 2016 FY | - CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Aurora Cannabis Inc. | 20.47 Million CAD | 105.011% |
| Avicanna Inc. | -7.35 Million CAD | 86.051% |
| Avant Brands Inc. | 4.83 Million CAD | 121.216% |
| Cardiol Therapeutics Inc. | -27.87 Million CAD | 96.32% |
| Crescita Therapeutics Inc. | 45 Thousand CAD | 2380.0% |
| Knight Therapeutics Inc. | 40.89 Million CAD | 102.509% |
| MediPharm Labs Corp. | -10.47 Million CAD | 90.208% |
| OrganiGram Holdings Inc. | -207.61 Million CAD | 99.506% |
| Canopy Growth Corporation | -312.82 Million CAD | 99.672% |
| Willow Biosciences Inc. | -11.06 Million CAD | 90.724% |
| Auxly Cannabis Group Inc. | -10.82 Million CAD | 90.522% |